Stage
Acquired | AcquiredAbout BioFactor Therapeutics
Developer of novel pharmaceutical approaches for the treatment of gastrointestinal disorders. The company's research is currently focussed around a proprietary bioactive peptide that has demonstrated antisecretory effects in animals and human healthy volunteers.
BioFactor Therapeutics Headquarter Location
Stockholm,
Sweden
46 8 442 58 50
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.